1) Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007; 448: 561-6
|
|
|
2) Sun S, Schiller JH, Gazdar AF, et al. Lung cancer in never smokers-different disease. Nat Rev Cancer. 2007; 7: 778-90
|
|
|
3) Herbst RS, Heymach JV, Lippman SM, et al. Lung Cancer. N Engl J Med. 2008; 25: 1367-80
|
|
|
4) Dick JE. Stem cell concepts review cancer research. Blood. 2008; 112: 4793-807
|
|
|
5) Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003; 425: 836-41
|
|
|
6) Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001; 414: 105-11
|
|
|
7) Li L, Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res. 2006; 66: 4553-7
|
|
|
8) Gilbertson RJ, Rich J. Glioblastoma stem cells and the vascular niche. Nat Rev Cancer. 2007; 7: 733-6
|
|
|
9) Ishikawa F, Yoshida S, Saito Y, et al. Chemo-therapy-resistant human AML stem cells home to and engraft within the bone marrow endosteal region. Nat Biotechnol. 2007; 25: 1315-21
|
|
|
10) Diehn M, Cho RW, Lobo NA, et al. Association of reactive oxygen species levels and radio-resistance in cancer stem cells. Nature. 2009; 458: 780-3
|
|
|
11) Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive heamatopoietic cell. Nat Med. 1997; 3: 730-7
|
|
|
12) Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003; 100: 3983-8
|
|
|
13) Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63: 5821-8
|
|
|
14) Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005; 65: 10946-51
|
|
|
15) O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating growth in immunodeficient mice. Nature. 2007; 445: 106-10
|
|
|
16) Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon cancer initiating cells. Nature. 2007; 445: 111-5
|
|
|
17) Hermann PC, Huber SL, Herrier T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007; 1: 313-23
|
|
|
18) Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007; 67: 1030-7
|
|
|
19) Chiba T, Kita K, Zheng YW, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology. 2006; 44: 240-51
|
|
|
20) Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007; 104: 973-8
|
|
|
21) Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005; 121: 823-35
|
|
|
22) Ling TY, Kuo MD, Li CL, et al. Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus(SARS-CoV)infection in vitro. Proc Natl Acad Sci U S A. 2006; 103: 9530-5
|
|
|
23) Dovey JS, Zacharek SJ, Kim CF, et al. Bmi1 is critical for lung tumorigenesis and bronchio-alveolar stem cell expansion. Proc Natl Acad Sci U S A. 2008; 105: 11857-62
|
|
|
24) Ventura JJ, Tenbaum S, Perdiguero E, et al. p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat Genetics. 2007; 39: 750-8
|
|
|
25) Yanagi S, Kishimoto H, Kawahara K, et al. Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J Clin Invest. 2007; 117: 2929-40
|
|
|
26) Ji H, Li D, Chen L, et al. The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Cancer Cell. 2006; 9: 485-95
|
|
|
27) Eramo A, Lotti F, Sette G, et al. Identification and expansion of the tumorigenic lung cancer stem population. Cell Death Differ. 2008; 15: 504-15
|
|
|
28) Ho MM, Ng AV, Lam S, et al. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 2007; 67: 4827-33
|
|
|
29) Jiang F, Qiu Q, Khanna A, et al. ALDH1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res. 2009; 7: 330-8
|
|
|
30) Gutova M, Najbauer J, Gevorgyan A. Identification of uPAR-positive chemoresistant cells in small cell lung cancer. PLoS ONE. 2007; 2: e243
|
|
|
31) Jiang T, Collins BJ, Jin N, et al. Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Cancer Res. 2009; 69: 845-54
|
|
|
32) Beier D, Hau P, Proescholdt M, et al. CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characterics and molecular profiles. Cancer Res. 2007; 67: 4010-5
|
|
|
33) Patrawala L, Calhoun T, Schneider BR, et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG- cancer cells are similarly tumorigenic. Cancer Res. 2005; 65: 6207-19
|
|
|
34) Shmelkov SV, Butler JM, Hooper AT, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cell initiate tumors. J Clin Invest. 2008; 118: 2111-20
|
|
|
35) Bar EE, Chaudhry A, Lin A, et al. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells. 2007; 25: 2524-33
|
|
|
36) Shih LM Wang TL. Notch signaling, gamma-secretase inhibitors, and cancer therapy. Cancer Res. 2007; 67: 1879-82
|
|
|
37) Meuwissen R, Berns A. Mouse models for human lung cancer. Genes Dev. 2005; 19: 643-64
|
|
|
38) Kim CF. Paving the road for lung stem cell biology: bronchioalveolar stem cells and other putative distal lung stem cells. Am J Physiol Lung Cell Mol Physiol. 2007; 293: 1092-8
|
|
|